Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

Abstract

Constitutive activation of signal transducer and activator of transcription (STAT) proteins has been detected in a wide variety of human primary tumor specimens and tumor cell lines including blood malignancies, head and neck cancer, and breast cancer. We have previously demonstrated a high frequency of Stat3 DNA-binding activity that is constitutively-induced by an unknown mechanism in human breast cancer cell lines possessing elevated EGF receptor (EGF-R) and c-Src kinase activities. Using tyrosine kinase selective inhibitors, we show here that Src and JAK family tyrosine kinases cooperate to mediate constitutive Stat3 activation in the absence of EGF stimulation in model human breast cancer cell lines. Inhibition of Src or JAKs results in dose-dependent suppression of Stat3 DNA-binding activity, which is accompanied by growth inhibition and induction of programmed cell death. In addition, transfection of a dominant-negative form of Stat3 leads to growth inhibition involving apoptosis of breast cancer cells. These results indicate that the biological effects of the Src and JAK tyrosine kinase inhibitors are at least partially mediated by blocking Stat3 signaling. While EGF-R kinase activity is not required for constitutive Stat3 activation in breast cancer cells, EGF stimulation further increases STAT DNA-binding activity, consistent with an important role for EGF-R in STAT signaling and malignant progression. Analysis of primary breast tumor specimens from patients with advanced disease revealed that the majority exhibit elevated STAT DNA-binding activity compared to adjacent non-tumor tissues. Our findings, taken together, suggest that tyrosine kinases transduce signals through Stat3 protein that contribute to the growth and survival of human breast cancer cells in culture and potentially in vivo.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  • Akira S . 1999 Stem Cells 17: 138–146

  • Akira S . 2000 Oncogene 19: 2607–2611

  • Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A, Kitamura T . 2000 J. Biol. Chem. 275: 24407–24413

  • Besser D, Bromberg JF, Darnell Jr JE, Hanafusa H . 1999 Mol. Cell. Biol. 19: 1401–1409

  • Biscardi JS, Tice DA, Parsons SJ . 1999 Adv. Cancer Res. 76: 61–119

  • Bowman T, Garcia R, Turkson J, Jove R . 2000 Oncogene 19: 2474–2488

  • Bromberg JF, Darnell Jr JE . 2000 Oncogene 19: 2468–2473

  • Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE . 1998 Mol. Cell. Biol. 18: 2553–2558

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE . 1999 Cell 98: 295–303

  • Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, de Groot RP . 1996 J. Biol. Chem. 271: 13221–13227

  • Cance WG, Liu ET . 1995 Breast Cancer Res. Treat 35: 105–114

  • Cao X, Tay A, Guy GR, Tan YH . 1996 Mol. Cell. Biol. 16: 1595–1603

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Catlett-Falcone R, Dalton WS, Jove R . 1999a Curr. Opin. Oncol. 11: 490–496

  • Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R . 1999b Immunity 10: 105–115

  • Chaturvedi P, Sharma S, Reddy EP . 1997 Mol. Cell. Biol. 17: 3295–3304

  • Chaturvedi P, Reddy MV, Reddy EP . 1998 Oncogene 16: 1749–1758

  • Coffer PJ, Koenderman L, de Groot RP . 2000 Oncogene 19: 2511–2522

  • Cohen BD, Siegall CB, Bacus S, Foy L, Green JM, Hellstrom I, Hellstrom KE, Fell HP . 1998 Biochem. Soc. Symp. 63: 199–210

  • Danial NN, Rothman P . 2000 Oncogene 19: 2523–2531

  • Darnell Jr JE . 1997 Science 277: 1630–1635

  • Darnell Jr JE . 1998 J. Interferon. Cytokine Res. 18: 549–554

  • David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, Johnson GR . 1996 J. Biol. Chem. 271: 9185–9188

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • Dearolf CR . 1999 Cell. Mol. Life Sci. 55: 1578–1584

  • Decker T, Kovarik P . 1999 Cell. Mol. Life Sci. 55: 1535–1546

  • Demoulin JB, Uyttenhove C, Lejeune DAM, Groner B, Renald JC . 2000 Cancer Res. 60: 3971–3977

  • Egan C, Pang A, Durda D, Cheng HC, Wang JH, Fujita DJ . 1999 Oncogene 18: 1227–1237

  • Fernandes A, Hamburger AW, Gerwin BI . 1999 Int. J. Cancer 83: 564–570

  • Frank DA, Varticovski L . 1996 Leukemia 10: 1724–1730

  • Fry DW . 1999 Pharmacol. Ther. 82: 207–218

  • Garcia R, Jove R . 1998 J. Biomed. Sci. 5: 79–85

  • Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R . 1997 Cell Growth Differ. 8: 1267–1276

  • Gullick WJ, Srinivasan R . 1998 Breast Cancer Res. Treat. 52: 43–53

  • Hirano T, Ishihara K, Hibi M . 2000 Oncogene 19: 2548–2556

  • Ihle JN, Stravapodis D, Parganas E, Thierfelder W, Feng J, Wang D, Teglund S . 1998 Cancer J. Sci. Am. 4: Suppl 1 S84–S91

  • Ilaria Jr RL, Van Etten RA . 1996 J. Biol. Chem. 271: 31704–31710

  • Kim H, Muller WJ . 1999 Exp. Cell. Res. 253: 78–87

  • Kloth MT, Biscardi JS, Tice DA, Parsons SJ, Silva CM . 2001 Manuscript submitted

  • Kraker AJ, Hartl BG, Amar AM, Barvian MR, Hollis Showalter HDH, Moore CW . 2000 Biochem. Pharmacol. 60: 885–898

  • Laudano AP, Buchanan JM . 1986 Proc. Natl. Acad. Sci. USA 83: 892–896

  • Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, Stark GR . 1996 Mol. Cell. Biol. 16: 369–375

  • Levitzki A . 1999 Pharmacol. Ther. 82: 231–239

  • Levy DE . 1999 Cell. Mol. Life Sci. 55: 1559–1567

  • Lin TS, Mahajan S, Frank DA . 2000 Oncogene 19: 2496–2504

  • Luttrell DK, Lee A, Lansing TJ, Crosby RM, Jung KD, Willard D, Luther M, Rodriguez M, Berman J, Gilmer TM . 1994 Proc. Natl. Acad. Sci. USA 91: 83–87

  • Luttrell DK, Luttrell LM, Parsons SJ . 1988 Mol. Cell. Biol. 8: 497–501

  • Ma L, Gauville C, Berthois Y, Degeorges A, Millot G, Martin PM, Calvo F . 1998 Int. J. Cancer 78: 112–119

  • Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ . 1995 Proc. Natl. Acad. Sci. USA 92: 6981–6985

  • Moasser MM, Srethapakdi M, Sachar KS, Kraker AJ, Rosen N . 1999 Cancer Res. 59: 6145–6152

  • Morrissey JJ, Raney S . 1998 Cell Biol. Int. 22: 413–419

  • Mui AL . 1999 Cell. Mol. Life Sci. 55: 1547–1558

  • Muthuswamy SK, Muller WJ . 1994 Adv. Cancer Res. 64: 111–123

  • Nelson KL, Rogers JA, Bowman TL, Jove R, Smithgall TE . 1998 J. Biol. Chem. 273: 7072–7077

  • Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R, Yu H . 1999 Cancer Res. 59: 5059–5063

  • Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE . 1999 J. Biol. Chem. 274: 17209–17218

  • Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE . 1992 Cancer Res. 52: 4773–4778

  • Parsons JT, Parsons SJ . 1997 Curr. Opin. Cell. Biol. 9: 187–192

  • Rajkumar T, Gullick WJ . 1994 Breast Cancer Res. Treat. 29: 3–9

  • Reddy EP, Korapati A, Chaturvedi P, Rani S . 2000 Oncogene 19: 2532–2547

  • Ruff-Jamison S, Chen K, Cohen S . 1993 Science 261: 1733–1736

  • Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP . 1997 Cancer Res. 57: 978–987

  • Schindler C, Brutsaert S . 1999 Cell. Mol. Life Sci. 55: 1509–1522

  • Sheffield LG . 1998 Biochem. Biophys. Res. Commun. 250: 27–31

  • Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . 1996 Oncogene 13: 247–254

  • Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB . 2000 Oncogene 19: 2612–2618

  • Song JI, Grandis JR . 2000 Oncogene 19: 2489–2495

  • Tice DA, Biscardi JS, Nickles AL, Parsons SJ . 1999 Proc. Natl. Acad. Sci. USA 96: 1415–1420

  • Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R . 1998 Mol. Cell. Biol. 18: 2545–2552

  • Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M . 1996 Mol. Cell. Biol. 16: 1759–1769

  • Wagner BJ, Hayes TE, Hoban CJ, Cochran BH . 1990 EMBO J. 9: 4477–4484

  • Wang YZ, Wharton W, Garcia R, Kraker A, Jove R, Pledger WJ . 2000 Oncogene 19: 2075–2085

  • Watson CJ, Miller WR . 1995 Br. J. Cancer 71: 840–844

  • Wilson LK, Luttrell DK, Parsons JT, Parsons SJ . 1989 Mol. Cell. Biol. 9: 1536–1544

  • Wilson LK, Parsons SJ . 1990 Oncogene 5: 1471–1480

  • Yeh TC, Pellegrini S . 1999 Cell. Mol. Life Sci. 55: 1523–1534

  • Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R . 1995 Science 269: 81–83

  • Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R . 2000 J. Biol. Chem. 275: 24935–24944

  • Zhong Z, Wen Z, Darnell Jr JE . 1994 Science 264: 95–98

  • Zong CS, Zeng L, Jiang Y, Sadowski HB, Wang LH . 1998 J. Biol. Chem. 273: 28065–28072

  • Zuyao N, Wei L, Leman ES, Gao AC . 2000 Cancer Res. 60: 1225–1228

Download references

Acknowledgements

This work was supported by the Angela Musatte Russo Foundation and NIH grants CA55652 and CA82533 (to R Jove). The authors wish to thank Drs Neal Rosen, Mark Moasser, Donald Fujita and Alex Aller for providing human breast cancer cell lines, Dr Lori Hazelhurst for assistance with cell cycle analysis, members of the laboratory for stimulating discussions, and the Moffitt Cancer Center Tumor Bank, Flow Cytometry and Molecular Imaging Core Facilities.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, R., Bowman, T., Niu, G. et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20, 2499–2513 (2001). https://doi.org/10.1038/sj.onc.1204349

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204349

Keywords

This article is cited by

Search

Quick links